Published in Surgery on December 01, 1992
Unilateral Clearance for Primary Hyperparathyroidism in Selected Patients with Multiple Endocrine Neoplasia Type 1. World J Surg (2016) 1.58
Double parathyroid adenomas. Clinical and biochemical characteristics before and after parathyroidectomy. Ann Surg (1993) 1.03
Hereditary hyperparathyroidism-a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbecks Arch Surg (2015) 1.03
Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors. Medicine (Baltimore) (2013) 1.00
Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT. Ann Surg (2008) 0.98
The optimal surgical treatment for primary hyperparathyroidism in MEN1 patients: a systematic review. World J Surg (2011) 0.92
Factors predicting outcome of total thyroidectomy in young patients with multiple endocrine neoplasia type 2: a nationwide long-term follow-up study. World J Surg (2010) 0.90
Multiple endocrine neoplasia type 1 parathyroid adenoma development over time. World J Surg (2004) 0.86
Care for patients with multiple endocrine neoplasia type 1: the current evidence base. Fam Cancer (2011) 0.84
Causes and treatment of recurrent hyperparathyroidism after subtotal parathyroidectomy in the presence of multiple endocrine neoplasia 1. World J Surg (2010) 0.81
Bilateral neck exploration in primary hyperparathyroidism--when is it selected and how is it performed? World J Surg (2009) 0.81
MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics. Neuroendocrinology (2015) 0.80
Surgical approach in patients with hyperparathyroidism in multiple endocrine neoplasia type 1: total versus partial parathyroidectomy. Clinics (Sao Paulo) (2012) 0.77
Functioning glucagonoma associated with primary hyperparathyroidism: multiple endocrine neoplasia type 1 or incidental association? BMC Cancer (2012) 0.75
Long-Term Surveillance of Treated Hyperparathyroidism for Multiple Endocrine Neoplasia Type 1: Recurrence or Hypoparathyroidism? World J Surg (2016) 0.75
Aortopulmonary window parathyroid gland causing primary hyperparathyroidism in men type 1 syndrome. Fam Cancer (2016) 0.75
Two G protein oncogenes in human endocrine tumors. Science (1990) 4.46
Total thyroidectomy: the treatment of choice for patients with differentiated thyroid cancer. Ann Surg (1982) 2.22
AACE/AAES medical/surgical guidelines for clinical practice: management of thyroid carcinoma. American Association of Clinical Endocrinologists. American College of Endocrinology. Endocr Pract (2001) 2.15
Familial nonmedullary thyroid cancer. An emerging entity that warrants aggressive treatment. Arch Surg (1995) 2.00
Can localization studies be used to direct focused parathyroid operations? Surgery (2001) 1.84
Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Cancer (2000) 1.73
Diagnosis, treatment, and outcome of follicular thyroid carcinoma. Cancer (1993) 1.67
Reoperative thyroid surgery. Surgery (1992) 1.67
Parathyroid carcinoma versus parathyroid adenoma in patients with profound hypercalcemia. Surgery (1987) 1.61
Total thyroidectomy or thyroid lobectomy in patients with low-risk differentiated thyroid cancer: surgical decision analysis of a controversy using a mathematical model. World J Surg (2000) 1.61
Localization of abnormal parathyroid glands of the mediastinum with MR imaging. Radiology (1993) 1.60
Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med (1996) 1.57
Novel method of assessing surgical margin status in laparoscopic specimens. Urology (2001) 1.49
Differentiated thyroid cancer: "complete" rational approach. World J Surg (2000) 1.47
Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival. Cancer (2001) 1.46
Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy. A case-control study. Ann Surg (1995) 1.45
Accuracy of fine-needle aspiration cytology in patients with radiation-induced thyroid neoplasms. Br J Surg (2003) 1.45
Recurrent hyperparathyroidism. Ann Surg (1976) 1.43
Parathyroid surgery: we still need traditional and selective approaches. J Endocrinol Invest (2005) 1.39
Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited. World J Surg (2001) 1.35
Carcinoids associated with multiple endocrine neoplasia syndromes. Am J Surg (1987) 1.34
Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest (1991) 1.32
Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach. Surgery (1991) 1.29
Reoperation for persistent or recurrent primary hyperparathyroidism. Arch Surg (1996) 1.22
Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Surgery (2000) 1.22
Increased serum levels of a parathyroid hormone-like protein in malignancy-associated hypercalcemia. Ann Intern Med (1989) 1.21
Familial thyroid cancer. Curr Opin Oncol (2001) 1.21
Localization and reoperation results for persistent and recurrent parathyroid carcinoma. Arch Surg (2001) 1.17
Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid. J Clin Endocrinol Metab (1997) 1.17
Localization of insulinomas. Arch Surg (1999) 1.16
Insulinoma--experience from 1950 to 1995. West J Med (1998) 1.15
Well-differentiated thyroid cancer. Curr Probl Surg (1994) 1.14
Selective modified radical neck dissection for papillary thyroid cancer-is level I, II and V dissection always necessary? World J Surg (2006) 1.13
Endogenous biologically active human parathyroid hormone: measurement by a guanyl nucleotide-amplified renal adenylate cyclase assay. J Clin Endocrinol Metab (1981) 1.12
Laparoscopic bilateral adrenalectomy: results for 30 consecutive cases. Surg Endosc (2008) 1.11
Calciphylaxis in secondary hyperparathyroidism. Diagnosis and parathyroidectomy. Arch Surg (1991) 1.10
Tumoral calcinosis. Controversies in the etiology and alternatives in the treatment. Arch Surg (1993) 1.10
Parathyroid variants: US evaluation. Radiology (1987) 1.10
Evaluation of solitary cold thyroid nodules by echography and thermography. Am J Surg (1975) 1.10
Therapeutic controversy: Thyroid surgery--the choice. J Clin Endocrinol Metab (1998) 1.10
The reasons for failure in parathyroid operations. Arch Surg (1989) 1.09
Primary hyperparathyroidism. A surgical perspective. Endocrinol Metab Clin North Am (1989) 1.09
Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients. Surgery (1999) 1.09
Cell surface sialoprotein alterations in metastatic murine colon cancer cell lines selected in an animal model for colon cancer metastasis. Cancer Res (1990) 1.09
The laparoscopic cigarette sponge. J Urol (2001) 1.08
Laparoscopic adrenalectomy. Comparison of the lateral and posterior approaches. Arch Surg (1996) 1.07
Transperitoneal preperitoneal laparoscopic lumbar incisional herniorrhaphy. J Urol (2001) 1.07
Parathyroid cysts. Am J Surg (1978) 1.06
Intraoperative parathyroid aspiration and parathyroid hormone assay as an alternative to frozen section for tissue identification. World J Surg (2000) 1.04
Surgical considerations and approach to thyroid cancer. Endocrinol Metab Clin North Am (1996) 1.04
Double parathyroid adenomas. Clinical and biochemical characteristics before and after parathyroidectomy. Ann Surg (1993) 1.03
Diagnosis and treatment of thyroid, parathyroid, and thyroglossal duct cysts. J Clin Endocrinol Metab (1979) 1.02
Clinical profile of primary hyperparathyroidism in adolescents and young adults. Clin Endocrinol (Oxf) (1998) 1.01
Thyroid-stimulating immunoglobulin bioassay using cultured human thyroid cells. J Clin Endocrinol Metab (1981) 1.01
TSH suppression in the management of thyroid nodules and thyroid cancer. World J Surg (1981) 1.00
Primary hyperparathyroidism in younger and older patients: symptoms and outcome of surgery. World J Surg (1992) 1.00
The laminin alpha 1 chain Ile-Lys-Val-Ala-Val (IKVAV)-containing peptide promotes liver colonization by human colon cancer cells. Cancer Res (1995) 1.00
The efficacy and limitations of percutaneous endoscopic gastrostomy. Arch Surg (1992) 0.99
Neutralizing vascular endothelial growth factor activity inhibits thyroid cancer growth in vivo. Surgery (2000) 0.99
Significance of lymph node metastasis in differentiated thyroid cancer. Am J Surg (1978) 0.99
Parathyroid adenoma, hyperplasia, and carcinoma: localization, technical details of primary neck exploration, and treatment of hypercalcemic crisis. Surg Oncol Clin N Am (1998) 0.99
Establishment of a highly differentiated thyroid cancer cell line of Hürthle cell origin. Thyroid (1998) 0.98
Central nervous system manifestations of hyperparathyroidism. Am J Med (1978) 0.97
Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer. Arch Surg (2000) 0.96
Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo. J Clin Endocrinol Metab (1994) 0.96
Postoperative adrenal hemorrhage. Ann Surg (1975) 0.95
Stimulatory effect of vasoactive intestinal polypeptide on human normal and neoplastic thyroid tissue. Surgery (1988) 0.95
Parathyroid scanning by computed tomography. Radiology (1983) 0.95
Localization studies in patients with persistent or recurrent hyperparathyroidism. Surgery (1985) 0.94
Localizing studies in patients with persistent or recurrent hyperparathyroidism. Surgery (1987) 0.94
Well differentiated thyroid cancer. Scand J Surg (2004) 0.94